Aligos Therapeutics (ALGS) Earnings Date, Estimates & Call Transcripts $39.84 +1.49 (+3.89%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Aligos Therapeutics Latest Earnings SummaryActual EPS (Nov. 6) -$3.07 Missed By -$0.92 Consensus EPS (Nov. 6) -$2.15 Aligos Therapeutics posted Q3 2024 earnings on November 6, 2024, reporting an EPS of -$3.07, which missed analysts' consensus estimates of -$2.15 by $0.92. Quarterly revenue was reported to be $1.27 million, above the consensus estimate of $1 million. With a trailing EPS of -$13.32, Aligos Therapeutics' earnings are expected to decrease next year, from ($10.36) to ($11.92) per share. Get Aligos Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aligos Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataALGS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ALGS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Aligos Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.19-$0.19-$0.19Q2 20241-$0.16-$0.16-$0.16Q3 20242-$4.40-$0.17-$2.29Q4 20242-$1.83-$0.19-$1.01FY 20246-$6.58-$0.71-$3.65Q1 20251-$1.85-$1.85-$1.85Q2 20251-$1.95-$1.95-$1.95Q3 20251-$2.13-$2.13-$2.13Q4 20251-$2.19-$2.19-$2.19FY 20254($8.12)($8.12)($8.12) Aligos Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/6/2024Q3 2024-$2.15-$3.07 -$0.92-$3.07$1.00M$1.27M8/6/2024Q2 2024-$4.00$0.75+$4.75$0.03-$1.06M5/7/2024Q1 2024-$4.75-$5.50 -$0.75-$0.22-$0.99M3/12/2024Q4 2023-$6.75-$5.50+$1.25-$0.22$3.20M$2.68M11/2/2023Q3 2023-$12.00-$10.25+$1.75-$0.41$5.00M$2.15M8/3/2023Q2 2023-$12.50-$10.75+$1.75-$0.43-$6.89M Get the Latest News and Ratings for ALGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023Q1 2023-$12.25-$13.25 -$1.00-$0.53$4.30M$2.72M3/9/2023Q4 2022-$12.25-$12.75 -$0.50-$0.51$2.80M$3.54M Aligos Therapeutics Earnings - Frequently Asked Questions When did Aligos Therapeutics announce their last quarterly earnings? Aligos Therapeutics (NASDAQ:ALGS) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on ALGS's earnings history. Did Aligos Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aligos Therapeutics (NASDAQ:ALGS) missed the analysts' consensus estimate of ($2.15) by $0.92 with a reported earnings per share (EPS) of ($3.07). Learn more on analysts' earnings estimate vs. ALGS's actual earnings. How much revenue does Aligos Therapeutics generate each year? Aligos Therapeutics (NASDAQ:ALGS) has a recorded annual revenue of $6.00 million. How much profit does Aligos Therapeutics generate each year? Aligos Therapeutics (NASDAQ:ALGS) has a recorded net income of -$87.68 million. ALGS has generated -$13.32 earnings per share over the last four quarters. What is Aligos Therapeutics's EPS forecast for next year? Aligos Therapeutics's earnings are expected to decrease from ($10.36) per share to ($11.92) per share in the next year. More Earnings Resources from MarketBeat Related Companies Cartesian Therapeutics Earnings Results Monte Rosa Therapeutics Earnings Results Esperion Therapeutics Earnings Results Alpha Teknova Earnings Results ChromaDex Earnings Results Organogenesis Earnings Results Zevra Therapeutics Earnings Results Verve Therapeutics Earnings Results Corvus Pharmaceuticals Earnings Results SIGA Technologies Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. This page (NASDAQ:ALGS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALGS Stock Alerts